DK122896B - Fremgangsmåde til rensning og eventuelt koncentrering af animalsk ribonucleinsyrevirus, såkalt RNA- virus, luftvejssyncytialvirus eller rubellavirus. - Google Patents

Fremgangsmåde til rensning og eventuelt koncentrering af animalsk ribonucleinsyrevirus, såkalt RNA- virus, luftvejssyncytialvirus eller rubellavirus.

Info

Publication number
DK122896B
DK122896B DK173168AA DK173168A DK122896B DK 122896 B DK122896 B DK 122896B DK 173168A A DK173168A A DK 173168AA DK 173168 A DK173168 A DK 173168A DK 122896 B DK122896 B DK 122896B
Authority
DK
Denmark
Prior art keywords
virus
purifying
ribonucleic acid
respiratory syncytial
rubella
Prior art date
Application number
DK173168AA
Other languages
Danish (da)
English (en)
Inventor
A Kanarek
G Tribe
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK122896B publication Critical patent/DK122896B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18551—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK173168AA 1967-04-19 1968-04-18 Fremgangsmåde til rensning og eventuelt koncentrering af animalsk ribonucleinsyrevirus, såkalt RNA- virus, luftvejssyncytialvirus eller rubellavirus. DK122896B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1797667 1967-04-19

Publications (1)

Publication Number Publication Date
DK122896B true DK122896B (da) 1972-04-24

Family

ID=10104487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK173168AA DK122896B (da) 1967-04-19 1968-04-18 Fremgangsmåde til rensning og eventuelt koncentrering af animalsk ribonucleinsyrevirus, såkalt RNA- virus, luftvejssyncytialvirus eller rubellavirus.

Country Status (10)

Country Link
BE (1) BE713942A (enrdf_load_stackoverflow)
CH (1) CH532123A (enrdf_load_stackoverflow)
DE (1) DE1767220A1 (enrdf_load_stackoverflow)
DK (1) DK122896B (enrdf_load_stackoverflow)
ES (1) ES352868A1 (enrdf_load_stackoverflow)
FR (1) FR1560875A (enrdf_load_stackoverflow)
GB (1) GB1226743A (enrdf_load_stackoverflow)
IL (1) IL29770A (enrdf_load_stackoverflow)
NL (1) NL6805558A (enrdf_load_stackoverflow)
YU (1) YU34714B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7216091A (enrdf_load_stackoverflow) * 1971-12-03 1973-06-05
ZA814386B (en) * 1980-07-01 1982-07-28 Nat Res Dev Production of viral antigens

Also Published As

Publication number Publication date
GB1226743A (enrdf_load_stackoverflow) 1971-03-31
FR1560875A (enrdf_load_stackoverflow) 1969-03-21
YU34714B (en) 1979-12-31
BE713942A (enrdf_load_stackoverflow) 1968-10-21
ES352868A1 (es) 1969-09-01
NL6805558A (enrdf_load_stackoverflow) 1968-10-21
CH532123A (de) 1972-12-31
YU86668A (en) 1979-07-10
DE1767220A1 (de) 1971-08-19
IL29770A0 (en) 1968-06-20
IL29770A (en) 1971-10-20

Similar Documents

Publication Publication Date Title
DK118249B (da) Fremgangsmåde til fremstilling af 1-substituerede 5-pyridyl-1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK124404B (da) Fremgangsmåde til fremstilling af 2-arylamino-1,3-diazacycloalkener-(2) eller syreadditionssalte deraf.
DK108985C (da) Fremgangsmåde til fremstilling af mæslingevaccine indeholdende levende, svækket mæslingevirus.
DK131935B (da) Analogifremgangsmåde til fremstilling af aminoalkynyllaktamforbindelser eller syreadditionssalte deraf.
DK122896B (da) Fremgangsmåde til rensning og eventuelt koncentrering af animalsk ribonucleinsyrevirus, såkalt RNA- virus, luftvejssyncytialvirus eller rubellavirus.
DK134705B (da) Fremgangsmåde til fremstilling af enzyminhibitorer, kaldet leupeptiner, og syreadditionssalte.
DK152214C (da) Et-trins fremgangsmaade til fremstilling af erythomycyl-amin-11,12-carbonat eller farmaceutisk acceptable syreadditionssalte deraf
DK112091B (da) Fremgangsmåde til fremstilling af et antibiotisk stof, enduracidin, eller syreadditionssalte deraf.
DK124340B (da) Fremgangsmåde til fremstilling af stærk svækket, levende Newcastle-syge-virus-vaccine.
DK123710B (da) Analogifremgangsmåde til fremstilling af N,N-dimethyl-3-(3-hydroxyphenyl)-propionamidiner eller -acrylamidiner eller syreadditionssalte deraf.
DK135285B (da) Analogifremgangsmåde til fremstilling af 5-substituerede 5,10-dihydro-11H-dibenzo(b,e)(1,4)diazepin-11-oner eller 11-substituerede 5, 11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner eller syreadditionssalte deraf.
DK122433B (da) Fremgangsmåde til koncentrering, rensning og/eller isolering af enzymer eller deres inhibitorer.
DK109463C (da) Fremgangsmåde til rensning af humant eller animalsk plasminogen.
DK109453C (da) Fremgangsmåde til fremstilling af N,N'-substituerede diaminoethanforbindelser eller syreadditionssalte deraf.
DK131030B (da) Fremgangsmåde til fremstilling af N-diethylaminoethyl-2-methoxy-4-amino-5-chlorbenzamid eller syreadditionssalte eller kvaternære ammoniumsalte heraf.
DK112952B (da) Fremgangsmåde til fremstilling af N-(4-alkylaminoalkoxy-benzyl)-3,4-dialkoxy-benzamider eller syreadditionssalte deraf.
DK104399C (da) Fremgangsmåde til fremstilling af 3-dehydrofusidinsyre og 3,11-didehydrofusidinsyre eller salte af disse.
DK124755B (da) Analogifremgangsmåde til fremstilling af 2,3-disubstituerede quinazolin-4-on-derivater eller syreadditionssalte eller kvaternære ammoniumderivater deraf.
DK115703B (da) Fremgangsmåde til fremstilling af N-alkylpolyhydrobenzazepinopyridoindoler eller syreadditionssalte deraf.
DK122659B (da) Analogifremgangsmåde til fremstilling af N-substituerede 2-phenoxy-2-phenylacetamider eller syreadditionssalte heraf, som er egnede til retablering af normal hjerterytme.
DK128000B (da) Fremgangsmåde til fremstilling af N-substituerede aminoalkyl-S,S-diphenylsulfoximiner eller syreadditionssalte eller kvaternære ammoniumsalte heraf.
DK129195B (da) Analogifremgangsmåde til fremstilling af 11-aminoalkyl-dibenzo[a,d]-cycloheptatrien-derivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK125704B (da) Analogifremgangsmåde til fremstilling af et amidin eller et syreadditionssalt deraf.
DK125886B (da) Fremgangsmåde til fremstilling af 2,3-diklor-4-butyryl-fenoxyeddikesyre eller dennes ammoniumsalte.
DK124483B (da) Fremgangsmåde til rensning af carboxypeptidase B.